Patient
SITE008-0136
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE008 (KOR) (Dr. Kim)
consented 2026-02-09
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-02-20 (study day 189); relationship: NOT RELATED
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-02-18 (study day 187); relationship: not assessed
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-01-13 (study day 151); relationship: not assessed
Grade 3 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-01-01 (study day 139); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.